Novel In-Office Injectables for the Dermatology–Rheumatology Patient: Botulinum Toxin, Sodium Thiosulfate, and Hyaluronidase. (2026). Canadian Dermatology Today, 7(3), 4-10. https://doi.org/10.58931/cdt.2026.73167